Indian patients with CHST3-related chondrodysplasia with congenital joint dislocations.
Swati SinghPrince JacobSiddaramappa Jagdish PatilMamta MuranjanHitesh ShahKatta Mohan GirishaGandham Sri Lakshmi BhavaniPublished in: American journal of medical genetics. Part A (2023)
CHST3-related chondrodysplasia with congenital joint dislocations (CDCJD, #MIM 143095), is a rare genetic skeletal disorder caused by biallelic loss of function variants in CHST3. CHST3 is critical for the sulfation of chondroitin sulfate. This study delineates the clinical presentation of nine individuals featuring the key symptoms of CDCJD; congenital joint (knee and elbow) dislocations, short trunk short stature progressive vertebral anomalies, and metacarpal shortening. Additional manifestations include irregular distal femoral epiphysis, supernumerary carpal ossification centers, bifid humerus, club foot, and cardiac abnormalities. Sanger sequencing was carried out to investigate molecular etiology in eight patients and exome sequencing in one. Genetic testing revealed five homozygous variants in CHST3 (four were novel and one was previously reported). All these variants are located on sulfotransferase domain of CHST3 protein and were classified as pathogenic/ likely pathogenic. We thus report on nine individuals with CHST3-related chondrodysplasia with congenital joint dislocations from India and suggest monitoring the health of cardiac valves in this condition.
Keyphrases
- copy number
- single cell
- left ventricular
- end stage renal disease
- healthcare
- public health
- ejection fraction
- total knee arthroplasty
- minimally invasive
- gene expression
- prognostic factors
- aortic valve
- intellectual disability
- autism spectrum disorder
- physical activity
- postmenopausal women
- body composition
- transcatheter aortic valve replacement
- single molecule
- lower limb
- human health
- aortic stenosis